Presentation is loading. Please wait.

Presentation is loading. Please wait.

Early and locally advanced breast cancer

Similar presentations


Presentation on theme: "Early and locally advanced breast cancer"— Presentation transcript:

1 Early and locally advanced breast cancer
Nb numbers in brackets denote relevant paragraphs in the breast cancer service guidance Recovery Package: Whole needs assessment. A treatment summary (including surveillance programme) sent to the patient and their GP. Information on likely side-effects of treatment and how best to manage these. Information on potential symptoms of recurrence/secondary cancers and what to do in these occurrences. Key contact point for rapid re-entry if symptoms of recurrence are experienced or if serious side effects become apparent. Access to a patient education and support event, such as a Health and Wellbeing Clinic, to prepare the person of the transition to supported self-management, including advice on healthy lifestyle and physical activity. Referral to a health trainer is often helpful. Signposting to rehabilitation, work and financial support services. Advanced disease (please see metastatic breast cancer pathway) No cancer- reassure discharge Staging tests (imaging) (3.2.2) 1st OPA: Triple Assessment Examination Mammogram/ ultrasound of breast and axilla Biopsy (3.2.1) 2nd OPA: Surgical, ER and HER2 receptor results (3.2.3) Surgery: Wide local excision or mastectomy +/- reconstruction and axillary staging or treatment ( ) GP Referral Stratified Open Access Follow up (3.2.54, appendix 5) Neo adjuvant systemic therapy: Chemotherapy +/- Biological therapy or endocrine therapy (3.2.16, ) Holistic Needs Assessment and access to a CNS (3.2.8, 3.2.9) Adjuvant therapy: Endocrine +/- Chemotherapy +/- Anti-HER2 therapy +/- Radiotherapy +/- Biological therapy +/- consider clinical trial ( , appendix 4) Consider clinical trial (3.2.7, ) Recovery Package at end of acute treatment (3.2.45, and above) Screening Breast MDT (weekly) (3.2.5, 3.2.6) MDT (post-operative results) Cure – 75% Family History Advanced/metastatic disease – 25% (please see metastatic breast cancer pathway) Mammographic surveillance (3.2.55) Consider clinical trial (3.2.7, ) A&E Areas covered by breast cancer service guidance Abbreviations: A&E – Accident and Emergency CNS – Clinical Nurse Specialist ER – Oestrogen Receptor GP – General Practitioner HER2 – Human Epithelial Growth Factor receptor OPA = Outpatient Appointment MDT – Multidisciplinary team Key: = Primary care = Secondary care Breast Cancer Clinical Reference Group, October 2015

2 Metastatic breast cancer
Nb numbers in brackets denote relevant paragraphs in the breast cancer service guidance 1st OPA: Triple assessment (if not previously done) (3.2.1, ) Holistic needs assessment by specialist metastatic cancer nurse (3.2.47, ) Palliative Endocrine therapy +/- Chemotherapy +/- Anti-HER2 therapy +/- Radiotherapy +/- Biological therapy +/- Surgery +/- Bisphosphonates (3.2.49, ) Health needs assessment by specialist metastatic cancer nurse (3.2.47, ) Consider clinical trial (3.2.52) OPA attendance and monitoring scans 2nd and subsequent lines of systemic therapy (3.2.49, ) Recurrence Breast MDT (3.2.46) 2nd OPA: Treatment plan Disease progression End of life care Staging: Imaging and biopsy of primary or metastases (3.2.2) First presentation Palliative care as and when appropriate Areas covered by breast cancer service guidance Key: = Secondary care Abbreviations: OPA = Outpatient Appointment MDT – Multidisciplinary team Breast Cancer Clinical Reference Group, October 2015


Download ppt "Early and locally advanced breast cancer"

Similar presentations


Ads by Google